Open letter to doctor's and other health care providers:
Treating pain using phytocannabinoids isn't a new idea but now it is a scientific fact. The use of THCA or Tetrahydrocannabinolic acid, has been shown effective for treatment of pain associated with various cancers and chemotherapy. You may be surprised to learn how this specific cannabinoid relieves pain due to inflammation, including severe pain.
Articles about the use of THC and CBD are well known but the big news is the remarkable effectiveness of THCA. Tetrahydrocannabinolic acid is one of many non psychoactive constituents found in cannabis. Studies show that THCA compounded with other cannabinoids is superior to THC and CBD for relieving pain due to inflammation, while building the endocannabinoid system. THCA functions in four ways: (a) Releases COX-1, (b) Inhibits COX-2, (c) Inhibits TNFAlpha, (d) Releases interleukin-10. THC or CBD combined, do not have the same spectrum of effects as THCA.
Extracted from raw cannabis, THCA is not only safe and has a low cost, but proven exceptionally effective for reducing pain due to inflammation, without intoxication in the correct dosages. Most importantly, its effects support better quality of life without dangerous side effects for in firmed and hospice patients. GW Pharmaceuticals, the leading developer of phytocannabinoid medicine including Sativex® have published extensively about THCA, THC and CBD, and their role in maintaining the endocannabinoid system in all mammals. You can review these studies and U.S. patent information at GWpharm.com and CBDScience.com.
A THCA compound is distributed by Alta California Botanicals to licensed dispensaries throughout California. Pain Relief Tincture™ contains an approximate dosage of 10 mg/ml THCA in an ethanol base digestive, for fast effective relief. Product information and patient protocols are available on www.tryalta.com